Showing 18,541 - 18,560 results of 106,247 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( e ((non decrease) OR (point decrease)) ))', query time: 1.23s Refine Results
  1. 18541
  2. 18542
  3. 18543
  4. 18544

    Reducing SIRT1 activity increases, and increasing SIRT1 expression decreases, mitochondrial enzymes in C<sub>2</sub>C<sub>12</sub> myotubes and rat skeletal muscle. by Kazuhiko Higashida (351645)

    Published 2013
    “…Values are means ± SE for 6–10 experiments per group. <i>p</i><0.5 versus control. (B) Suppression of SIRT1 activity by expression of dominant-negative SIRT1 H355A in rat triceps muscle by electroporation resulted in increases in mitochondrial proteins. …”
  5. 18545
  6. 18546
  7. 18547

    Average negative, positive, and net work data for all the walking conditions: Level (0°), downhill (−5°,−10°), and uphill (+5°,+10°) (n = 12). by Nikolaos Papachatzis (12959894)

    Published 2023
    “…During uphill walking, the knee increased the magnitude of net positive work (0° vs. 10°: p = 0.005; +5° vs. +10°: p = 0.012). <b>(D)</b> The hip increased the magnitude of the net negative work when the slope of walking decreased (0° vs. −5°: p = 0.002; −0° vs. −10°: p = 0.002), while uphill walking shifted and increased the hip’s net mechanical behavior (0° vs. +5°: p = 0.002; 0° vs +10°: p = 0.002; +5° vs. +10°: p = 0.002). …”
  8. 18548
  9. 18549

    Pathway analysis of genes differentially expressed upon RBM10KD in GLC20 cells. by Julie J. Loiselle (4183750)

    Published 2017
    “…(B) MSigDB Hallmark gene sets enriched at a false discovery rate of below 5% upon RBM10KD in GLC20 cells. …”
  10. 18550

    Effects of telomestatin on Topo III signals and Topo III/TRF2/BLM protein levels in MRC5-V1/YFP-Topo III cells. by Nassima Temime-Smaali (260017)

    Published 2009
    “…<p>A, Representative images of untreated MRC5-V1/YFP-Topo III cells and cells treated with 2 µM telomestatin for 48 h; Topo III was detected by fluorescence of YFP-tagged Topo III (green) or by immunofluorescence using D6 antibody (red). …”
  11. 18551
  12. 18552

    BMP non-canonical pathway activation is increased in the absence of FLNB <i>in vivo</i> and <i>in vitro</i>. by Jennifer Zieba (2577121)

    Published 2016
    “…(A) P-Smad1,5,8 levels remain unchanged in <i>Flnb</i><sup><i>–/–</i></sup>when compared with <i>Flnb</i><sup><i>+/+</i></sup>, N = 6. …”
  13. 18553

    TOP2α/170 mRNA and protein levels in K562, drug resistant K/VP.5, and K562/SSedit-2 cells. by Victor A. Hernandez (12647320)

    Published 2022
    “…Subsequent reduced coverage for E20 in K/VP.5 cells (underlined in black/denoted with a red arrow) is consistent with decreased TOP2α/170 protein expression levels (see Fig 5E). …”
  14. 18554
  15. 18555
  16. 18556
  17. 18557
  18. 18558

    Loss of FAM83A expression induces apoptosis and inhibits PI3K/Akt signaling. by Courtney A. Bartel (3993173)

    Published 2017
    “…(C) Live cells were stained with an antibody detecting the early apoptosis marker Annexin V. Knockdown of FAM83A resulted in elevated expression of Annexin V. …”
  19. 18559

    Inducing incentive sensitization of exercise reinforcement among adults who do not regularly exercise—A randomized controlled trial by Kyle D. Flack (2141455)

    Published 2019
    “…Repeated exposures to a reinforcer may increase its reinforcing value (i.e., incentive sensitization). …”
  20. 18560